Matt Kremer
About
Matt Kremer is from Philadelphia, Pennsylvania, United States. Matt is currently Co-Founder at Hula Therapeutics, located in Philadelphia, Pennsylvania, United States. Matt also works as President at PC-CAR Partners LLC, a job Matt has held since Jan 2022. Another title Matt currently holds is President at Tantigen Bio. In Matt's previous role as a Business Development and Sales Manager, New Markets, Cell Culture Technologies at Pall Life Sciences, Matt worked in Philadelphia, PA until Jan 2018. Prior to joining Pall Life Sciences, Matt was a North American Sales, Cell Culture Technologies at ATMI Life Sciences (acquired by Pall Corporation, February 2014) and held the position of North American Sales, Cell Culture Technologies at Philadelphia, PA. Prior to that, Matt was a Principal at Kremer Consulting from Jan 2008 to Jan 2012. Matt started working as Senior Director, Business Development at Neose Technologies in Jan 1997.
Matt Kremer's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Matt Kremer's current jobs
Discovery and development of CAR-Ts targeting peptide MHC targets on pediatric solid tumors.
Discovery of cancer associated peptide MHC targets.
Univercells Technologies is developing the scale-X single-use, fixed-bed bioreactor and the NevoLine integrated microfacility to reduce the manufacturing cost of vaccines, gene therapies and antibodies.
Life sciences business development consulting
Matt Kremer's past jobs
Novel single use bioreactor technologies for production of stem cells, vaccines and viral vectors, proteins and antibodies in adherent and suspension cell culture.
Novel single use bioreactor technologies for production of stem cells, vaccines and viral vectors, proteins and antibodies in adherent and suspension cell culture. ATMI LifeSciences was acquired by Pall Corporation in February 2014
Consulting services: - Strategy consulting for:early stage companies - U.S. business development for small European companies seeking to enter the U.S. market.